‘Rescheduling’ cannabis would ease restrictions on science, opening the door to the largest investment in cannabis research we’ve seen to date

Rescheduling cannabis could mark a major shift in research, but it alone will not eliminate the scientific, regulatory and patient-access challenges that have shaped medical cannabis for decades, says clinical researcher Raymond Palidora…
Read More